- Oral Peanut Immunotherapy
The Food Allergy Center of MGH is conducting a research study examining the effectiveness of peanut immunotherapy for subjects with severe, persistent peanut allergy.
Subjects needed:
Individuals between the ages 7-21 years who have been diagnosed with a peanut allergy by a positive skin prick test or positive blood test for peanut and a history of objective clinical symptoms within one hour after ingestion of peanuts.
The study requires visits to Massachusetts General Hospital. During these visits you/your child would undergo physical exams, blood tests, immunotherapy dosing determination, immunotherapy dosage administration, and food challenges. The research study could last up to 36 months. Parking expenses will be reimbursed.
For more information, please call 617-643-5952 or email abrennan3@partners.org.
Subjects needed:
Individuals between the ages 7-21 years who have been diagnosed with a peanut allergy by a positive skin prick test or positive blood test for peanut and a history of objective clinical symptoms within one hour after ingestion of peanuts.
The study requires visits to Massachusetts General Hospital. During these visits you/your child would undergo physical exams, blood tests, immunotherapy dosing determination, immunotherapy dosage administration, and food challenges. The research study could last up to 36 months. Parking expenses will be reimbursed.
For more information, please call 617-643-5952 or email abrennan3@partners.org.
Institution – MGH - Massachusetts General Hospital, Boston, MA
Principal Investigator – Wayne G Shreffler, MD, PhD
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name – Alisa K Brennan
Email – foodallergy@mgh.harvard.edu
Phone – 617-643-5952
